-
Acadia Pharmaceuticals can apply for approval of Parkinson's disease psychosis drug early
SAN DIEGO — The Food and Drug Administration is granting an expedited application process to a company that has developed a treatment for a condition related to Parkinson's disease, meaning that it can cancel a planned late-stage clinical trial, the company said.